Thomson B J, Finch R G
Department of Infectious Diseases, University of Nottingham, Nottingham, UK.
Clin Microbiol Infect. 2005 Feb;11(2):86-94. doi: 10.1111/j.1469-0691.2004.01061.x.
Hepatitis C virus (HCV) infection is a major public health problem. Up to 3% of the world's population is infected with HCV, and at least 200 000 adults in the UK carry the virus. Of those exposed to HCV, 80% become chronically infected, and at least 30% of carriers develop chronic liver disease, including cirrhosis and hepatocellular carcinoma. This review provides an overview of selected features of the molecular biology and pathogenesis of HCV infection, and thereafter discusses in detail the epidemiology of HCV, the hepatic and extra-hepatic diseases caused by the virus, and the current treatment options for both acute and chronic virus infection. The special cases of healthcare workers, prison inmates and individuals coinfected with human immunodeficiency virus and HCV are considered in detail.
丙型肝炎病毒(HCV)感染是一个重大的公共卫生问题。全球高达3%的人口感染了HCV,英国至少有20万成年人携带该病毒。在接触过HCV的人群中,80%会转为慢性感染,至少30%的携带者会发展为慢性肝病,包括肝硬化和肝细胞癌。本综述概述了HCV感染的分子生物学和发病机制的选定特征,随后详细讨论了HCV的流行病学、该病毒引起的肝脏和肝外疾病,以及急性和慢性病毒感染的当前治疗选择。还详细考虑了医护人员、监狱囚犯以及同时感染人类免疫缺陷病毒和HCV的个体的特殊情况。